| Synonyms: | |
| Status: | Approved (1949) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 50D9XSG0VR |
Structure
| InChI Key | HAWPXGHAZFHHAD-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C5H11Cl2N |
| Molecular Weight | 156.06 |
| AlogP | 1.4 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 3.24 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 8.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 73 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Mycosis Fungoides | 2 | D009182 | ClinicalTrials |
Related Entries
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 51-75-2 |
| ChEBI | 28925 |
| ChEMBL | CHEMBL427 |
| DrugBank | DB00888 |
| DrugCentral | 1647 |
| EPA CompTox | DTXSID2020975 |
| FDA SRS | 50D9XSG0VR |
| Human Metabolome Database | HMDB0015025 |
| Guide to Pharmacology | 7218 |
| KEGG | C07115 |
| PharmGKB | PA450336 |
| PubChem | 4033 |
| SureChEMBL | SCHEMBL3861 |
| ZINC | ZINC000002539484 |
CONTENTS